Cusack Thomas (CIK 2094824) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-03). Recent activity: Buy HRTX (53,960 shares), Buy HRTX (37,879 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-03 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Director | Buy | 53,960 | $0 |
| 2025-11-12 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Director | Buy | 37,879 | $0 |
Source: SEC Form 4 filings · as of 2026-02-03